Prospects for the use of rapeseed oil and its derived fat products in the prevention of cardiovascular diseases in overweighted individuals

In light of the growing prevalence of overweight-related diseases, an urgent priority is to develop effective, evidence-based preventive nutritional strategies aimed at reducing cardiometabolic risk. Vegetable oils, rich in polyunsaturated and monounsaturated fatty acids, as well as such biologically active components as phospholipids, phytosterols, and vitamins, represent a promising component in dietary improvement programs. This study conducted a comparative evaluation of refined, deodorized rapeseed oil, sunflower oil, and an optimized vegetable-oil blend called “Osoboe,” developed by the RUE Scientific-Practical Center of the NAS of Belarus for Food. Overweighted volunteers participated in trials designed to assess the nutritional value and preventive potential of these oils. Results showed that incorporating rapeseed oil into the diets of overweighted individuals led to statistically significant improvements in blood lipid profiles (reductions in total cholesterol, LDL-cholesterol, and apolipoprotein B), increased metabolic rate, and a reduction in the biological age of blood vessels. The “Osoboe” blend exhibited moderate anti-atherogenic activity, whereas sunflower oil produced no significant changes. These findings confirm the prospects of using rapeseed oil, and fat products derived from it, in diets for overweighted individuals, particularly within cardiovascular disease prevention strategies.

1. Calder P. C. Polyunsaturated fatty acids and inflammation. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2006, vol. 75, no. 3, pp. 197–202. https://doi.org/10.1016/j.plefa.2006.05.012

2. World Health Organization. Diet, nutrition and the prevention of chronic diseases: report of a joint WHO/FAO expert consultation. WHO Technical Report Series, no. 916. Geneva, WHO, 2003. 149 p.

3. Mozaffarian D., Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. European Journal of Clinical Nutrition, 2009, vol. 63, suppl. 2, pp. S22–S33. https://doi.org/10.1038/sj.ejcn.1602976

4. World Health Organization. REPLACE trans fat: an action package to eliminate industrially-produced trans-fat from the global food supply: trans fat free by 2023. Geneva: WHO, 2018. 1 p.

5. Simopoulos A. P. The importance of the omega-6/omega-3 ratio. Biomedicine & Pharmacotherapy, 2002, vol. 56, no. 8, pp. 365–379. https://doi.org/10.1016/S0753-3322(02)00253-6

6. Candela C. G., Lopez L. M. B., Kohen V. L. Importance of a balanced omega 6/omega 3 ratio for the maintenance of health. Nutritional recommendations. Nutrición Hospitalaria, 2011, vol. 26, no. 2, pp. 323–329. https://doi.org/10.3305/nh.2011.26.2.5117

7. Albert C. M., Campos H., Stampfer M. J., Ridker P. M., Manson J. E., Willett W. C., Ma J. Blood levels of long-chain n–3 fatty acids and the risk of sudden death. The New England Journal of Medicine, 2002, vol. 346, no. 15, pp. 1113–1118. https://doi.org/10.1056/NEJMoa012918

8. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet, 1999, vol. 354, no. 9177, pp. 447–455. https://doi.org/10.1016/S0140-6736(99)07072-5

9. Casula M., Olmastroni E., Gazzotti M., Galimberti F., Zambon A., Catapano A. L. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials. Pharmacological Research, 2020, vol. 160, art. 105060. https://doi.org/10.1016/j.phrs.2020.105060

10. Miller P. E., Van Elswyk M., Alexander D. D. Long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. American Journal of Hypertension, 2014, vol. 27, no. 7, pp. 885–896. https:/doi.org/10.1093/ajh/hpu024

11. Simopoulos A. P. An increase in the omega-6/omega-3 fatty acid ratio increases the risk for obesity. Nutrients, 2016, vol. 8, no. 3, art. 128. https://doi.org/10.3390/nu8030128

12. Perova N. V., Metel’skaya V. A., Sokolov E. I., Shchukina G. N., Fomina V. M. Dietary fatty acids. Effects on the risk of cardiovascular diseases. Ratsional’naya farmakoterapiya v kardiologii = Rational Pharmacotherapy in Cardiology, 2011, vol. 7, no. 5, pp. 620–627 (in Russian). https://doi.org/10.20996/1819-6446-2011-7-5-620-627

13. Subbotina M. A. Physiological aspects of the use of fats in the nourishment. Tekhnika i tekhnologiya pishchevykh proizvodstv = Food Processing: Techniques and Technology, 2009, no. 4 (15), pp. 54–57 (in Russian).

14. Dolgoluk I. V., Terechuk L.V., Trubnikova M. A., Starovojtova K. V. Vegetable oils as functional foods. Tekhnika i tekhnologiya pishchevykh proizvodstv = Food Processing: Techniques and Technology, 2014, no. 2 (33), pp. 122–125 (in Russian).

15. Jenkins D. J., Kendall C. W., McKeown-Eyssen G., Josse R. G., Silverberg J., Booth G. L. [et al.]. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA, 2008, vol. 300, no. 23, pp. 2742–2753. https://doi.org/10.1001/jama.2008.808

16. Korolevich N. G., Oganezov I. A., Lovkis L. K., Buga A. V. Current state of rapeseed and rapeseed oil production in the Republic of Belarus. Agropanorama, 2024, no. 4, pp. 36–42 (in Russian).

17. Republic of Belarus: statistical yearbook. Minsk, National Statistical Committee of the Republic of Belarus, 2024. 317 p. (in Russian).

18. Holme I., Aastveit A. H., Hammar N., Jungner I., Walldius G. Inflammatory markers, lipoprotein components and risk of major cardiovascular events in 65,005 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Atherosclerosis, 2010, vol. 213, no. 1, pp. 299–305. http://doi.org/10.1016/j.atherosclerosis.2010.08.049